Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Seiichi, Yano"'
Autor:
Seiichi Yano, Takashi Ishiuchi, Shusaku Abe, Satoshi H. Namekawa, Gang Huang, Yoshihiro Ogawa, Hiroyuki Sasaki
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
DNMT3A is known to methylate DNA at histone H3 lysine 36 (H3K36me3)-marked transcriptionally active regions in mouse oocytes. Here the authors show that DNMT3A is also guided by H3K36me2 to methylate broad domains in genic and intergenic loci, as wel
Externí odkaz:
https://doaj.org/article/d14052d145fd491295690d0b53f6bf95
Autor:
Chieko Yano, Maki Yokomoto-Umakoshi, Masamichi Fujita, Hironobu Umakoshi, Seiichi Yano, Norifusa Iwahashi, Shunsuke Katsuhara, Hiroki Kaneko, Masatoshi Ogata, Tazuru Fukumoto, Eriko Terada, Yayoi Matsuda, Ryuichi Sakamoto, Yoshihiro Ogawa
Publikováno v:
Bone Reports, Vol 17, Iss , Pp 101610- (2022)
Purpose: Bone and vascular diseases are considered to share pathogenic mechanisms. Excess glucocorticoids, key regulators of cardiovascular and metabolic homeostasis, may promote both diseases simultaneously. We used endogenous Cushing's syndrome (CS
Externí odkaz:
https://doaj.org/article/5cbbc11faf224527a29ccee74c7cb755
Autor:
Chihiro Sakaguchi, Kenji Ashida, Kenichi Kohashi, Kenji Ohe, Yoichi Fujii, Seiichi Yano, Yayoi Matsuda, Shohei Sakamoto, Ryuichi Sakamoto, Yoshinao Oda, Masatoshi Nomura, Yoshihiro Ogawa
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Increased urinary free cortisol in response to the oral administration of dexamethasone is a paradoxical reaction mainly reported in patients with primary pigmented nodular adrenocortical disease. Here, we describe the first case
Externí odkaz:
https://doaj.org/article/b25f751f280b43c5b502dd59bf5970b9
Autor:
Seiichi Yano, Kenji Ashida, Hiromi Nagata, Kenji Ohe, Naoko Wada, Yukina Takeichi, Yuki Hanada, Yuta Ibayashi, Lixiang Wang, Shohei Sakamoto, Ryuichi Sakamoto, Hiroshi Uchi, Motoaki Shiratsuchi, Masutaka Furue, Masatoshi Nomura, Yoshihiro Ogawa
Publikováno v:
BMC Endocrine Disorders, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Nivolumab, an anti-programmed cell death-1 monoclonal antibody, has improved the survival of patients with malignant melanoma. Despite its efficacy, nivolumab inconsistently induces thyroid dysfunction as an immune-related adverse
Externí odkaz:
https://doaj.org/article/5bd2e9d380954684be3d0d0d2083d326
Autor:
Masutaka Furue, Hiroshi Uchi, Nao Hasuzawa, Seiichi Yano, Shohei Sakamoto, Masatoshi Nomura, Naoko Wada, Kenji Ohe, Kenji Ashida, Chihiro Sakaguchi, Yayoi Matsuda, Yoshihiro Ogawa, Ryuichi Sakamoto
Publikováno v:
Current Oncology
Volume 26
Issue 1
Pages 4130-118
Volume 26
Issue 1
Pages 4130-118
Nivolumab, an anti&ndash
PD-1 antibody, is now considered an important therapeutic agent in several advanced malignancies. However, immune-related adverse events such as endocrinopathies have been reported with its use. Thyroid disorder and isol
PD-1 antibody, is now considered an important therapeutic agent in several advanced malignancies. However, immune-related adverse events such as endocrinopathies have been reported with its use. Thyroid disorder and isol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550343554ef9567f8b688916b11a3d05
https://doi.org/10.3747/co.26.4130
https://doi.org/10.3747/co.26.4130
Autor:
Masatoshi Nomura, Kenji Ohe, Naoko Wada, Seiichi Yano, Hiroshi Uchi, Hiromi Nagata, Kenji Ashida, Yayoi Matsuda, Keizo Ohnaka, Yoshihiro Ogawa, Shohei Sakamoto, Ryuichi Sakamoto, Masutaka Furue, Chihiro Sakaguchi
Publikováno v:
The American Journal of Case Reports
Patient: Female, 50 Final Diagnosis: Adrenal insufficiency Symptoms: Appetite loss • severe fatigue Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic Objective: Unusual clinical course Background: Ipilimumab is a therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0481b91c1b3465dbb4d9933fd54777c
http://europepmc.org/articles/PMC6354724
http://europepmc.org/articles/PMC6354724
Autor:
Chihiro Sakaguchi, Yuki Kurihara, Hitomi Umeguchi, Hiroshi Inoue, Nao Hasuzawa, Hiromasa Takenoshita, Shohei Sakamoto, Ryuichi Sakamoto, Kenji Ashida, Seiichi Yano
Publikováno v:
Journal of Oncology Practice. 14:449-451
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b5b32911a706b9d5fb1da7fc0d3cc1
https://doi.org/10.1200/jop.18.00076
https://doi.org/10.1200/jop.18.00076
Autor:
Yoichi Fujii, Kenji Ashida, Seiichi Yano, Kenji Ohe, Masatoshi Nomura, Ryuichi Sakamoto, Yoshihiro Ogawa, Kenichi Kohashi, Yoshinao Oda, Shohei Sakamoto, Yayoi Matsuda, Chihiro Sakaguchi
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Endocrine Disorders
BMC Endocrine Disorders
Background Increased urinary free cortisol in response to the oral administration of dexamethasone is a paradoxical reaction mainly reported in patients with primary pigmented nodular adrenocortical disease. Here, we describe the first case of subcli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed44caff59c41a0900b25b4c21feb6ac
https://doi.org/10.1186/s12902-019-0345-8
https://doi.org/10.1186/s12902-019-0345-8
Autor:
Seiichi Yano, Shohei Sakamoto, Kenji Ohe, Yukina Takeichi, Ryuichi Sakamoto, Masutaka Furue, Yuta Ibayashi, Hiroshi Uchi, Yuki Hanada, Naoko Wada, Lixiang Wang, Yoshihiro Ogawa, Motoaki Shiratsuchi, Masatoshi Nomura, Kenji Ashida, Hiromi Nagata
Publikováno v:
BMC Endocrine Disorders, Vol 18, Iss 1, Pp 1-6 (2018)
Background Nivolumab, an anti-programmed cell death-1 monoclonal antibody, has improved the survival of patients with malignant melanoma. Despite its efficacy, nivolumab inconsistently induces thyroid dysfunction as an immune-related adverse event (i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af23ad64daf7b87bd7685ede051842de
https://pubmed.ncbi.nlm.nih.gov/29884162
https://pubmed.ncbi.nlm.nih.gov/29884162
Publikováno v:
Folia Pharmacologica Japonica. 129:197-207
吸入ブデソニドは，持続性の局所抗炎症作用および気道選択性を有し，気管支喘息の治療薬としての高い効果が期待されてきた．細胞内のブデソニドは，エステル体では不活性だが，組
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce5f33b1ec0d01e3969aeffc76776b7
https://doi.org/10.1254/fpj.129.197
https://doi.org/10.1254/fpj.129.197